Our approach goes beyond simply prescribing a GLP-1 medication
This retrospective cohort study included 3,389 adult patients with obesity who initiated treatment with injectable semaglutide or liraglutide between July 1, 2015, and June 30, 2022
Fatigue affects 5-11% of patients and typically results from substantial caloric restriction due to appetite suppression, gastrointestinal side effects like nausea and vomiting, dehydration from reduced oral intake, or rapid metabolic changes during weight loss
So the smartest "weight loss stack" is really a GLP-1 + muscle-preservation setup: The GLP-1 drives the fat loss A GH peptide pairing like CJC-1295 + Ipamorelin supports lean mass and recovery while you are in a deficit Recovery peptides (BPC-157, TB-500) keep you training, and training is what protects muscle We go deep on this in Will Tirzepatide Make You Lose Muscle
doi: 10.1039/D0FO01643H 290 NichitoiMMJosceanuAMIsopescuRDIsopencuGOGeanaEICiucureCTet al